PAPER Gorter RP, Stephenson J, Nutma E, Anink J, de Jonge JC, Baron W, Jahreiβ MC, Belien JA, van Noort JM, Mijnsbergen C, Aronica E, Amor S
SEARCH RESULTS
15774 RESULTS
PAPER Ren Z, Yang M, Guan Z, Yu W
Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
Curr Alzheimer Res. 2019;16(1):39-48. PubMed: 30345917PAPER Yokoi T, Watanabe H, Yamaguchi H, Bagarinao E, Masuda M, Imai K, Ogura A, Ohdake R, Kawabata K, Hara K, Riku Y, Ishigaki S, Katsuno M, Miyao S, Kato K, Naganawa S, Harada R, Okamura N, Yanai K, Yoshida M, Sobue G
Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.
Front Aging Neurosci. 2018;10:304. Epub 2018 Oct 5 PubMed: 30344488PAPER Yakovleva OV, Lyashenko EA, Poluektov MG
[Dysfunction of the orexin system in Parkinson's disease].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):82-89. PubMed: 30346439PAPER Ning H, Wu Q, Han D, Yao T, Wang J, Lu W, Lv S, Jia Q, Li X
Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease.
Neuropathol Appl Neurobiol. 2018 Oct 22; PubMed: 30346044PAPER López-Erauskin J, Tadokoro T, Baughn MW, Myers B, McAlonis-Downes M, Chillon-Marinas C, Asiaban JN, Artates J, Bui AT, Vetto AP, Lee SK, Le AV, Sun Y, Jambeau M, Boubaker J, Swing D, Qiu J, Hicks GG, Ouyang Z, Fu XD, Tessarollo L, Ling SC, Parone PA, Shaw CE, Marsala M, Lagier-Tourenne C, Cleveland DW, Da Cruz S
ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
Neuron. 2018 Nov 21;100(4):816-830.e7. Epub 2018 Oct 18 PubMed: 30344044PAPER Chris Min K, Dockendorf MF, Palcza J, Tseng J, Ma L, Stone JA, Kleijn HJ, Hodsman P, Masuo K, Tanen M, Troyer MD, van Vugt M, Forman MS
Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study.
Clin Pharmacol Ther. 2019 May;105(5):1234-1243. Epub 2019 Jan 18 PubMed: 30347431PAPER La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C Jr, Jagust WJ, Jin LW, Klunk WE, Kofler J, Lesman-Segev OH, Lockhart SN, Lowe VJ, Masters CL, Mathis CA, McLean CL, Miller BL, Mungas D, O'Neil JP, Olichney JM, Parisi JE, Petersen RC, Rosen HJ, Rowe CC, Spina S, Vemuri P, Villemagne VL, Murray ME, Rabinovici GD
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
Alzheimers Dement. 2019 Feb;15(2):205-216. Epub 2018 Oct 19 PubMed: 30347188PAPER Podder A, Pandit M, Narayanan L
Drug Target Prioritization for Alzheimer's Disease Using Protein Interaction Network Analysis.
OMICS. 2018 Oct;22(10):665-677. PubMed: 30346884PAPER Gulácsy CE, Meade R, Catici DA, Soeller C, Pantos GD, Jones DD, Alibhai D, Jepson M, Valev VK, Mason JM, Williams RJ, Pudney CR
Excitation-Energy-Dependent Molecular Beacon Detects Early Stage Neurotoxic Aβ Aggregates in the Presence of Cortical Neurons.
ACS Chem Neurosci. 2019 Mar 20;10(3):1240-1250. Epub 2018 Nov 21 PubMed: 30346718PAPER Tsai YF, Yang DJ, Ngo TH, Shih CH, Wu YF, Lee CK, Phraekanjanavichid V, Yen SF, Kao SH, Lee HM, Huang VS, Shieh JC, Lin YF
Ganglioside Hp-s1 Analogue Inhibits Amyloidogenic Toxicity in Alzheimer's Disease Model Cells.
ACS Chem Neurosci. 2019 Jan 16;10(1):528-536. Epub 2018 Oct 26 PubMed: 30346715PAPER Chu D, Liu F
Pathological Changes of Tau Related to Alzheimer's Disease.
ACS Chem Neurosci. 2019 Feb 20;10(2):931-944. Epub 2018 Oct 23 PubMed: 30346708PAPER Okada Y, Okubo K, Ikeda K, Yano Y, Hoshino M, Hayashi Y, Kiso Y, Itoh-Watanabe H, Naito A, Matsuzaki K
Toxic Amyloid Tape: A Novel Mixed Antiparallel/Parallel β-Sheet Structure Formed by Amyloid β-Protein on GM1 Clusters.
ACS Chem Neurosci. 2019 Jan 16;10(1):563-572. Epub 2018 Oct 11 PubMed: 30346704PAPER Cho GM, Lee SY, Park JH, Kim MJ, Park KJ, Choi BT, Shin YI, Kim NG, Shin HK
Photobiomodulation using a low-level light-emitting diode improves cognitive dysfunction in the 5XFAD mouse model of Alzheimer's disease.
J Gerontol A Biol Sci Med Sci. 2018 Oct 20; PubMed: 30346494PAPER Chebotareva AD, Levin OS, Markov DD, Sychev DA, Grishina EA
[Is it personalized treatment of dementia based on the CYP2D6 gene polymorphism possible?]
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):90-94. PubMed: 30346440Current Filters
- Date Range : Oct 2018 to Oct 2019 x